← Leaderboards
David Stewart
University Of Tx Md Anderson Can Ctr
$5,039,756
Attributed
$5,039,756
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2009–15$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$5,039,756 · 2
By mechanism
N01$5,039,756 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Ronald Anthony Depinho$97,148,322
- Scott Kopetz$13,199,822
- James C Yao$2,907,879
- David S. Hong$3,694,798
- Powel Brown$21,822,596
Others in their field
Top investigators on “Therapeutic Development”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$547,603,444
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Judith S. Currier · University Of California Los Angeles$326,346,444
- Leonard Freedman · Leidos Biomedical Research, Inc.$311,659,176
Research focus
Therapeutic DevelopmentContractsData ReportingPhase 2 StudyClinical TrialsDrug DevelopmentCombined Modality TherapyMolecular TargetClinically RelevantResearch PersonnelProtocols DocumentationDevelopmental Therapeutics ProgramDrug IndustryToxic EffectNational Cancer InstituteNew AgentsOrganPatient PopulationPharmacodynamicsPharmacologyTumor TissueBaseBloodCancer Therapy Evaluation Program
Grant awards (8)
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS$658,768
N01 · FY2015 · CA · contact PI
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS$744,026
N01 · FY2014 · CA · contact PI
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS$451,851
N01 · FY2013 · CA · contact PI
TAS::75 0849::TAS EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS$1,170,480
N01 · FY2012 · CA · contact PI
TAS::75 0849::TAS EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS$766,616
N01 · FY2011 · CA · contact PI
Early Therapeutics Development with Phase II Emphasis$562,526
N01 · FY2011 · CA · contact PI
Early Therapeutics Development with Phase II Emphasis$348,986
N01 · FY2010 · CA · contact PI
Early Therapeutics Development with Phase II Emphasis$336,503
N01 · FY2009 · CA · contact PI